Search

Akm E. Ullah

Examiner (ID: 10221, Phone: (571)272-2361 , Office: P/2874 )

Most Active Art Unit
2874
Art Unit(s)
2874, 2606, 2501, 1734, 2899, 3621, 2838
Total Applications
3400
Issued Applications
3065
Pending Applications
95
Abandoned Applications
245

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7322080 [patent_doc_number] => 20040226053 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Methods of producing a target molecule in a transgenic animal and purification of the target molecule' [patent_app_type] => new [patent_app_number] => 10/863101 [patent_app_country] => US [patent_app_date] => 2004-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13763 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20040226053.pdf [firstpage_image] =>[orig_patent_app_number] => 10863101 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/863101
Methods of producing a target molecule in a transgenic animal and purification of the target molecule Jun 7, 2004 Abandoned
Array ( [id] => 7322078 [patent_doc_number] => 20040226052 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Methods of producing a target molecule in a transgenic animal and purification of the target molecule' [patent_app_type] => new [patent_app_number] => 10/862951 [patent_app_country] => US [patent_app_date] => 2004-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13761 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20040226052.pdf [firstpage_image] =>[orig_patent_app_number] => 10862951 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/862951
Methods of producing a target molecule in a transgenic animal and purification of the target molecule Jun 7, 2004 Abandoned
Array ( [id] => 7277676 [patent_doc_number] => 20040237127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Composition and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis and abnormal cell proliferation' [patent_app_type] => new [patent_app_number] => 10/860724 [patent_app_country] => US [patent_app_date] => 2004-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 32915 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20040237127.pdf [firstpage_image] =>[orig_patent_app_number] => 10860724 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/860724
Composition and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis and abnormal cell proliferation Jun 2, 2004 Issued
Array ( [id] => 585762 [patent_doc_number] => 07442688 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-28 [patent_title] => 'Composition and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis and abnormal cell proliferation' [patent_app_type] => utility [patent_app_number] => 10/860373 [patent_app_country] => US [patent_app_date] => 2004-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 15 [patent_no_of_words] => 32408 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/442/07442688.pdf [firstpage_image] =>[orig_patent_app_number] => 10860373 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/860373
Composition and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis and abnormal cell proliferation Jun 2, 2004 Issued
Array ( [id] => 7256211 [patent_doc_number] => 20040259829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-23 [patent_title] => 'Compositions and methods for sensitizing and inhibiting growth of human tumor cells' [patent_app_type] => new [patent_app_number] => 10/858271 [patent_app_country] => US [patent_app_date] => 2004-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13145 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20040259829.pdf [firstpage_image] =>[orig_patent_app_number] => 10858271 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/858271
Compositions and methods for sensitizing and inhibiting growth of human tumor cells May 31, 2004 Issued
Array ( [id] => 7116617 [patent_doc_number] => 20050069918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-31 [patent_title] => 'JAB1 as a prognostic marker and a therapeutic target for human cancer' [patent_app_type] => utility [patent_app_number] => 10/858869 [patent_app_country] => US [patent_app_date] => 2004-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 38552 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20050069918.pdf [firstpage_image] =>[orig_patent_app_number] => 10858869 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/858869
JAB1 as a prognostic marker and a therapeutic target for human cancer May 31, 2004 Abandoned
Array ( [id] => 7195758 [patent_doc_number] => 20050164218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Gene expression markers for response to EGFR inhibitor drugs' [patent_app_type] => utility [patent_app_number] => 10/857715 [patent_app_country] => US [patent_app_date] => 2004-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11953 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20050164218.pdf [firstpage_image] =>[orig_patent_app_number] => 10857715 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/857715
Gene expression markers for response to EGFR inhibitor drugs May 27, 2004 Abandoned
Array ( [id] => 7088954 [patent_doc_number] => 20050009067 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Expression profile of pancreatic cancer' [patent_app_type] => utility [patent_app_number] => 10/848259 [patent_app_country] => US [patent_app_date] => 2004-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 30895 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20050009067.pdf [firstpage_image] =>[orig_patent_app_number] => 10848259 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/848259
Expression profile of pancreatic cancer May 17, 2004 Abandoned
Array ( [id] => 7432642 [patent_doc_number] => 20040209840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-21 [patent_title] => 'Manipulation of arterial-venous identity' [patent_app_type] => new [patent_app_number] => 10/848191 [patent_app_country] => US [patent_app_date] => 2004-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5023 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20040209840.pdf [firstpage_image] =>[orig_patent_app_number] => 10848191 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/848191
Manipulation of arterial-venous identity May 17, 2004 Abandoned
Array ( [id] => 5642633 [patent_doc_number] => 20060281088 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-14 [patent_title] => 'Markers for lxr activation' [patent_app_type] => utility [patent_app_number] => 10/557720 [patent_app_country] => US [patent_app_date] => 2004-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6876 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20060281088.pdf [firstpage_image] =>[orig_patent_app_number] => 10557720 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/557720
Markers for lxr activation May 13, 2004 Abandoned
Array ( [id] => 7061150 [patent_doc_number] => 20050003511 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'New yeast-bacteria shuttle vector' [patent_app_type] => utility [patent_app_number] => 10/843542 [patent_app_country] => US [patent_app_date] => 2004-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6803 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20050003511.pdf [firstpage_image] =>[orig_patent_app_number] => 10843542 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/843542
New yeast-bacteria shuttle vector May 9, 2004 Abandoned
Array ( [id] => 7183312 [patent_doc_number] => 20040203077 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'Method and kit for quantitation of polypeptides' [patent_app_type] => new [patent_app_number] => 10/473043 [patent_app_country] => US [patent_app_date] => 2004-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4335 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20040203077.pdf [firstpage_image] =>[orig_patent_app_number] => 10473043 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/473043
Method and kit for quantitation of polypeptides May 3, 2004 Abandoned
Array ( [id] => 7206382 [patent_doc_number] => 20050043260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Wnt as a factor for cardiac myogenesis' [patent_app_type] => utility [patent_app_number] => 10/828669 [patent_app_country] => US [patent_app_date] => 2004-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 18389 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20050043260.pdf [firstpage_image] =>[orig_patent_app_number] => 10828669 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/828669
Wnt as a factor for cardiac myogenesis Apr 20, 2004 Abandoned
Array ( [id] => 5216020 [patent_doc_number] => 20070105101 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'Gene expression associated with osteobla st differentiation' [patent_app_type] => utility [patent_app_number] => 10/552319 [patent_app_country] => US [patent_app_date] => 2004-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23561 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20070105101.pdf [firstpage_image] =>[orig_patent_app_number] => 10552319 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/552319
Gene expression associated with osteobla st differentiation Apr 4, 2004 Abandoned
Array ( [id] => 5188402 [patent_doc_number] => 20070166710 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-19 [patent_title] => 'Methods for inhibiting adipogenesis and for treating type 2 diabetes' [patent_app_type] => utility [patent_app_number] => 10/551392 [patent_app_country] => US [patent_app_date] => 2004-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 21669 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20070166710.pdf [firstpage_image] =>[orig_patent_app_number] => 10551392 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/551392
Methods for inhibiting adipogenesis and for treating type 2 diabetes Mar 30, 2004 Abandoned
Array ( [id] => 7672949 [patent_doc_number] => 20040180830 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder' [patent_app_type] => new [patent_app_number] => 10/806515 [patent_app_country] => US [patent_app_date] => 2004-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 25735 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 175 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180830.pdf [firstpage_image] =>[orig_patent_app_number] => 10806515 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/806515
Methods and compositions for preventing and treating male erectile dysfunction Mar 21, 2004 Issued
90/006953 TRANSFORMED MAMMALIAN CELL AND USE THEREOF FOR THE PRODUCTION OF GLYCOPROTEINS Feb 26, 2004 Issued
Array ( [id] => 7258110 [patent_doc_number] => 20040260079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-23 [patent_title] => 'Cardiac-cell specific enhancer elements and uses thereof' [patent_app_type] => new [patent_app_number] => 10/780120 [patent_app_country] => US [patent_app_date] => 2004-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 10630 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20040260079.pdf [firstpage_image] =>[orig_patent_app_number] => 10780120 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/780120
Cardiac-cell specific enhancer elements and uses thereof Feb 16, 2004 Abandoned
Array ( [id] => 7263935 [patent_doc_number] => 20040241856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Methods and compositions for modulating stem cells' [patent_app_type] => new [patent_app_number] => 10/777028 [patent_app_country] => US [patent_app_date] => 2004-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18414 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20040241856.pdf [firstpage_image] =>[orig_patent_app_number] => 10777028 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/777028
Methods and compositions for modulating stem cells Feb 10, 2004 Abandoned
Array ( [id] => 7263483 [patent_doc_number] => 20040241714 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Methods of assessment of drug metabolizing enzymes' [patent_app_type] => new [patent_app_number] => 10/770538 [patent_app_country] => US [patent_app_date] => 2004-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 17178 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20040241714.pdf [firstpage_image] =>[orig_patent_app_number] => 10770538 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/770538
Methods of assessment of drug metabolizing enzymes Feb 3, 2004 Abandoned
Menu